Carnitine and Other Metabolites in Fibromyalgia a Clinical Perspective on a Mendelian Randomization Study
Minping Hong, Jianguo Wang, Xiaowen Huang, Qin Xu, Yujin Xiao, Keng Ling · 2025
Read Carnitine and Other Metabolites in Fibromyalgia a Clinical Perspective on a Mendelian Randomization Study by Minping Hong, Jianguo Wang, Xiaowen Huang, Qin Xu, Yujin Xiao, Keng Ling (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12746739.txt.
Description
Minping Hong and five co-authors published a 2025 study of whether blood chemicals, above all carnitine, help cause fibromyalgia, a chronic pain disorder with no reliable marker. The team first measured carnitine in the blood of 96 patients and healthy controls. They then used a genetic method, Mendelian randomization, which treats inherited variants as a natural experiment, to test 1,400 blood chemicals for causal links to the disease.
Carnitine ran clearly lower in patients than in controls. The genetic analysis flagged ten chemicals with possible causal links. Carnitine appeared protective: higher levels tied to lower risk. Four other chemicals looked protective and five looked risky. Reverse checks supported the findings. The authors call for larger studies in more varied populations before any treatment claims.
Catalog record
| CREATOR | Minping Hong, Jianguo Wang, Xiaowen Huang, Qin Xu, Yujin Xiao, Keng Ling |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |